Metabolic Health in Motion: A Global Insight to Metabolic Associated Liver Disease
This International Academic Conference will take place at the University of Iowa over two days. Internationally renowned experts will review the state of the art in MASLD, including epidemiology, risk factors, etiology, disease progression, lifestyle changes (dietary modifications, exercise programs), pharmacological, endoscopic and surgical treatments, liver transplant and organ donation, and disease outcomes.
Different levels of care and several medical specialties will be involved to provide a holistic overview.
Dates:
Friday, September 19, 2025, 8:00am - Saturday, September 20, 2025, 5:00pm
Location:
Hyatt Regency Coralville, Coralville, IA
Hotel website | Map/directions
Questions?
Please contact Taryn Owens at taryn-owens@uiowa.edu
Objectives and Aims
Objectives and Aims
- Raise awareness on MASLD and its consequences on health, including end-stage liver disease.
- Review the state of the art on MASLD and update the medical community on health goals for these patients.
- Enhance professional knowledge and skills through interactive sessions and networking opportunities with experts.
- Comprehensive Understanding of MASLD: Describe the origins, diagnosis, natural history, and pathophysiology of MASLD, distinguishing it from other liver diseases.
- Epidemiology and Prevention: Analyze the epidemiology of MASLD and evaluate effective prevention strategies from a public health perspective.
- Risk Assessment and Management: Develop evidence-based approaches for assessing and managing cardiovascular risk, cancer risk, and alcohol-related liver disease in patients with MASLD.
- Lifestyle and Therapeutic Interventions: Implement personalized lifestyle interventions, including dietary modifications and exercise programs, and assess the latest pharmacological, endoscopic, and surgical treatment options for MASLD.
- Multidisciplinary Collaboration: Design and sustain a multidisciplinary MASLD clinic, fostering collaboration across specialties to optimize patient outcomes.
- Transplantation Considerations: Identify and address the challenges of liver transplantation in MASH cirrhotic patients, including perioperative, anesthetic, and surgical considerations, as well as post-transplant care.
Target Audience
Specialties - Anesthesia, Cardiovascular Disease, Family Medicine, Internal Medicine, Surgery
Professions - Nurse, Nurse Practitioner, Physician, Physician Assistant
Credits
AMA PRA Category 1 Credits™ (13.50 hours), AAPA Category 1 CME credit (13.50 hours), ANCC Contact Hours (13.50 hours), Non-Physician Attendance (13.50 hours)
Additional Information
For a program specifics, registration details, and accreditation information, visit the University of Iowa Division of Continuing Medical Education conference overview page:
https://uiowa.cloud-cme.com/course/courseoverview?P=5&EID=73335
Program Brochure
Check out the brochure for the agenda and program speakers.
Topic List
- MASLD Unveiled: Origins, Diagnosis and Natural History
- Epidemiology of MASLD and Prevention Strategies from a Public Health Perspective
- Updated Mechanisms of MASLD Pathogenesis
- How are Obesity and MASLD linked to cancer?
- Assessment and Management of Cardiovascular Risk in patients with MASLD
- MetALD: How Alcohol and MASLD Interact
- Nutritional Assessment and Management in patients with MASLD
- Muscular Health: Sarcopenia in MASLD. How To Prescribe Exercise in our Clinics
- Pharmacotherapy of Obesity: An Update
- Surgical and Endoscopic Treatment Options in Patients with Obesity and MASLD
- MASH Therapeutic Landscape: Current Options and Opportunities for Future Combination Trials
- The Power of Teamwork: Building and Sustaining a Multidisciplinary MASLD Clinic
- Decompensated MASH cirrhotic patient: special considerations and contraindications to transplant
- Anesthetic Challenges Associated with Liver Transplant in MASH Patients
- Surgical Challenges Associated with Liver Transplant in MASH Patients
- Management of MASLD After Liver Transplantation